Brokerages Set Clearside Biomedical, Inc. (NASDAQ:CLSD) PT at $5.33
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among brokerages that have issued a report on […]
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among brokerages that have issued a report on […]
